Aclaris Therapeutics News - ACRS

Company Name	Stock Ticker Symbol	Market	Type
Aclaris Therapeutics Inc	ACRS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	1.21	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
1.22	1.21	1.30	1.21	1.21

more quote information »

Recent News

Date	Time	Source	Heading
3/05/2024	17:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	17:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/27/2024	07:30	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/27/2024	07:14	EDGAR2	Form 8-K - Current report
2/27/2024	07:00	GLOBE	Aclaris Therapeutics Reports Fourth Quarter and Full Year..
2/14/2024	20:32	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	14:06	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	14:24	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/05/2024	19:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/05/2024	19:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/05/2024	19:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/05/2024	19:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/05/2024	16:31	EDGAR2	Form 8-K/A - Current report: [Amend]
2/05/2024	16:30	EDGAR2	Form 8-K - Current report
1/19/2024	07:30	EDGAR2	Form 8-K - Current report
1/16/2024	07:00	GLOBE	Aclaris Therapeutics Announces Leadership Changes and..
1/10/2024	07:00	GLOBE	Aclaris Therapeutics Announces Top-line Results from 4-Week..
1/03/2024	16:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	16:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/19/2023	16:15	EDGAR2	Form 8-K - Current report
12/19/2023	16:01	GLOBE	Aclaris Therapeutics Provides Corporate Update
12/05/2023	16:01	GLOBE	Aclaris Therapeutics Announces Patent License Agreement with..
11/13/2023	07:42	EDGAR2	Form 8-K - Current report
11/13/2023	07:00	GLOBE	Aclaris Therapeutics Announces Top-line Results from 12-Week..
11/06/2023	07:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/2023	07:15	EDGAR2	Form 8-K - Current report
11/06/2023	07:00	GLOBE	Aclaris Therapeutics Reports Third Quarter 2023 Financial..
10/25/2023	16:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/23/2023	16:06	EDGAR2	Form 144 - Report of proposed sale of securities
10/03/2023	07:00	GLOBE	Aclaris Therapeutics Completes Enrollment in Phase 2b Study..
9/20/2023	07:00	GLOBE	Aclaris Therapeutics to Participate in the 2023 Cantor..
9/18/2023	08:00	EDGAR2	Form 8-K - Current report
9/18/2023	07:00	GLOBE	Aclaris Therapeutics Announces Positive Results from Phase 1..
9/07/2023	16:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/05/2023	17:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/28/2023	16:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/22/2023	16:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/21/2023	16:20	EDGAR2	Form 144 - Report of proposed sale of securities
8/07/2023	07:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/2023	07:15	EDGAR2	Form 8-K - Current report
8/07/2023	07:00	GLOBE	Aclaris Therapeutics Reports Second Quarter 2023 Financial..
8/03/2023	16:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/05/2023	16:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/13/2023	07:01	GLOBE	Aclaris Therapeutics Completes Enrollment in Phase 2b Study..
6/02/2023	07:00	GLOBE	Aclaris Therapeutics to Participate in Two June Healthcare..
5/08/2023	07:00	GLOBE	Aclaris Therapeutics Reports First Quarter 2023 Financial..
5/02/2023	07:01	GLOBE	Aclaris Therapeutics to Announce First Quarter 2023..